Even if ultimately approved, how much has this failure hurt the potential market they could address with the drug? I saw some suggest the drug could still work to protect against trace peanut exposure. Would you agree that is the likely market now and, if so, what are potential sales here? Or is a larger market still on the table?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.